Navigation Links
SmallCapSentinel.com Releases Market Actives List for JAZZ, MEXP, C, SAY, GOOG, AAPL
Date:6/11/2009

LAS VEGAS, June 11 /PRNewswire/ -- SmallCapSentinel.com has issued a Market Actives List for Thursday, specifically encouraging investors of the following equities to closely monitor trading activity for Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ), Marine Exploration, Inc. (OTC Bulletin Board: MEXP)- which traded roughly 14 times average daily volume Wednesday, Citigroup Inc. (NYSE: C), Satyam Computer Services Ltd. (NYSE: SAY), Google Inc. (Nasdaq: GOOG), Apple Inc. (Nasdaq: AAPL).

Additionally, a report has been made available regarding the aforementioned Marine Exploration, which engages in ocean exploration for buried treasure. Investors are greatly encouraged to put MEXP on their Watch Lists.

It is available at:

http://fispace.net/better-mousetraps/2009/05/17/mexp-on-a-treasure-hunt

From the report: Few experiences capture the fancy of the investor better than a literal treasure hunt. Unfortunately, the use of the phrase "treasure hunt" is most often deployed as metaphor and not as actual business plan. Not so for investors of Marine Exploration, Inc. (OTCBB:MEXP), a company driven by professional treasure hunters searching for sunken Spanish Galleons in the clear waters of the Caribbean Sea. The result for investors is a proverbial lottery ticket, where skill and chance blend into a public company.

FiSpace.Net is a dynamic investor social network where bloggers, message board readers, writers and more can communicate in an organized and productive way.

Register to receive exclusive information on emerging public companies at:

http://smallcapsentinel.com/register

To be featured in our publications please use the contact information below.

Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results. Integrity Media Inc. (IMI) provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience. The subject companies haven't always approved the statements made in this report. This report is neither a solicitation to buy nor offer to sell securities and is for information purposes only and shouldn't be used as basis for investment decisions. IMI isn't an investment advisor, analyst or licensed broker dealer and this report isn't investment advice. IMI has been paid fifteen-thousand dollars by Emerging Markets LLC a financial p.r. consultant to MEXP for this report and related advertising services. Paid reports constitute a conflict of interest as to IMI's ability to remain objective in communication regarding subject companies. S. Convery CRD#2495267.

    Contact:
    Kurt Divich, Editor
    Integrity Media Inc.
    702-396-1000


'/>"/>
SOURCE Integrity Media Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SmallCapSentinel.com Releases Report for Investors of Medical Device Companies SENO, STXS, EVVV, ANGO, THOR, and CPTS
2. Press Releases on BPA Studies By-Pass Scientific Process
3. American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines
4. Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis-C Virus (HCV)
5. Midwest Center for Stress and Anxiety Releases New Program, The Solution to Controlling Stress and Worry
6. Perot Systems Releases ARRA Webcast Featuring Leading Analyst Firm
7. Max Muscle Sports Nutrition Releases The Truth About Creatine
8. Avantpage Translations Releases White Paper on Capturing The Fastest Growing Healthcare Market In America
9. MedTrust Online Completes Second Round of Financing, Releases Next Generation Search Engine for Oncology Utilizing Dell eHealthcare Architecture Framework
10. Profiles International Releases New Report on Top 5 Management Failures and Remedies for Success
11. Scottish Widows Releases Critical Illness Cover Claims Figures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Brenntag Specialties, Inc.(BSI) ... Food & Beverage and Dietary Supplement market segments across ... and USA geographies east of the Rocky Mountains since 2012. Consistent performance ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... BantamPro L top-load case packer for pouches, bags, and flow wrapped products at ... help co-packers and specialty product manufacturers step up to semi-automatic or fully-automatic case ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... community enrichment program serving the greater Venice, FL area, has initiated a fundraiser ... in a car accident just four days after Christmas. To support this beautiful ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... of organizations. DocuSyst provides a cloud hosted environment for FileHold software that ... integration with various 3rd party applications using the FileHold web services API. DocuSyst ...
(Date:2/8/2016)... ... 08, 2016 , ... Joshua Rosenthal, PhD, Chief Scientific Officer ... use newly released government data on populations and physicians to better calculate risk ... the value they create to succeed in new economic models for value based ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... CARLSBAD, Calif. , Feb. 8, 2016  HemaFlo Therapeutics, ... Office (USPTO) has issued US Patent Number 9,119,880 covering the ... Dale Peterson , PhD, HemaFlo,s founder, said, "We ... technology." --> Dale Peterson , PhD, HemaFlo,s ... such a powerful technology." --> Dale ...
(Date:2/8/2016)... 8, 2016  Dynatronics Corporation (NASDAQ: DYNT ... devices and rehabilitation equipment for the physical therapy, ... Broncos, football team for winning the 2016 World ... Chairman and Chief Executive Officer.  "The Broncos have ... forward to enhancing their athletic achievements with our ...
(Date:2/8/2016)... RICHMOND, Calif. , Feb. 8, 2016 /PRNewswire/ ... leader in therapeutic genome editing, announced that the ... the Company,s Investigational New Drug (IND) application for ... a life-long therapy for Mucopolysaccharidosis Type I (MPS ... and enables Sangamo to initiate a Phase 1/2 ...
Breaking Medicine Technology: